# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-041399
Filing Date
2022-11-14
Accepted
2022-11-14 16:32:50
Documents
84
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | brhc10043851_10q.htm iXBRL | 10-Q | 2019825
2 | EXHIBIT 10.3 | brhc10043851_ex10-3.htm | EX-10.3 | 562983
3 | EXHIBIT 31.1 | brhc10043851_ex31-1.htm | EX-31.1 | 6656
4 | EXHIBIT 31.2 | brhc10043851_ex31-2.htm | EX-31.2 | 6664
5 | EXHIBIT 32.1 | brhc10043851_ex32-1.htm | EX-32.1 | 3969
6 | EXHIBIT 32.2 | brhc10043851_ex32-2.htm | EX-32.2 | 3980
12 |  | image00001.jpg | GRAPHIC | 2588
13 |  | img001_v1.jpg | GRAPHIC | 4428
14 |  | img002_v1.jpg | GRAPHIC | 3130
| Complete submission text file | 0001140361-22-041399.txt |  | 9855463

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA | erna-20220930.xsd | EX-101.SCH | 82249
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | erna-20220930_cal.xml | EX-101.CAL | 63822
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | erna-20220930_def.xml | EX-101.DEF | 409062
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | erna-20220930_lab.xml | EX-101.LAB | 965796
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | erna-20220930_pre.xml | EX-101.PRE | 571863
78 | EXTRACTED XBRL INSTANCE DOCUMENT | brhc10043851_10q_htm.xml | XML | 1385896

Mailing Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121
Business Address 10355 SCIENCE CENTER DRIVE SUITE 150 SAN DIEGO CA 92121 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11460 | Film No.: 221386473
SIC: 2834 Pharmaceutical Preparations